Business Wire

Soft Gear Announces Cloud Server Solution for Online Games "Strix Cloud"

Del

Soft Gear announces the server solution "Strix Cloud" for online game development, with a trial service limited to 111 accounts starting from November 1st, 2018.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181101005417/en/

Register the game application on the Strix Cloud website and set up the main game server and room se ...

Register the game application on the Strix Cloud website and set up the main game server and room servers. The attached image is the statistics page. Using the statistics page, you can check current status of the servers, such as changes in the number of concurrent connections, received/sent data, CPU utilization and similar metrics on the graph. In addition, it is being used to monitor the server and data transfer costs. (Graphic: Business Wire)

Background
Starting next year, 5G (5th generation) network operation will commence, further increasing achievable speeds and connection counts. For games and many applications, stable and high speed server technology is required. In order to provide network and server technologies more easily our company has been promoting cloud computing for server solutions. We have developed "Strix Cloud" - a highly scalable solution for online game development.

About Strix Cloud
Strix Cloud is a cloud version of "STRIX ENGINE" - a server solution developed for real-time action MMO games. With Strix Cloud it is possible to create a real-time server with just one click. Server development is very easy, as only simple modifications are required. Some of its strengths include the ability to process large numbers of messages at high speed and simultaneously connect a lot of users, which makes it viable for online games with near real-time nature.
The released Strix Cloud ver 1.0.0 contains Unity tools for easier client-side development. By using them the online game creation becomes very easy.

[Features of Strix Cloud]
• Set up game servers using web interface
Server programming is unnecessary, because the setup of the game server is completed with simple operations on the web interface. Even when increasing the number of servers, you can easily scale out using the same interface.

• Ability to handle a large number of simultaneous connections and high-speed processing of messages
As a high-performance server solution, Strix Cloud servers can handle a large number of concurrent connections and process messages at high-speed, which makes it a good candidate for any kind of game genres - from social games to real-time action ones.

• Many built-in helper functions for online game development
Strix SDKs contain many functions necessary for on-line game development, such as matching, replication (object synchronization), webhooks etc. In addition, Unity SDK plugin contains property synchronization and RPC, which makes handling the game-specific communication processing even easier.

• Specification information
Version: Strix Cloud ver. 1.0.0
Region: Tokyo, Singapore, USA, Europe, Australia
Supported Platforms: Windows, Linux, Mac, iOS, Android, Nintendo Switch
Supported game engine: Unity
Supported protocols: TCP, HTTP
Major functions: matching function, message relay (room function), replication (object synchronization), webhooks (communication with external servers), Unity SDK (provided plugin), application management, user management, instance management etc.

[Limited to 111 accounts! Start trial]
With the release of Strix Cloud ver. 1.0.0, we will commence a trial service limited to 111 accounts from November 1st, 2018. You can try Strix Cloud for free during the trial period. Please apply from our corporate site.
Strix Cloud application page URL: http://www.soft-gear.co.jp/strix_cloud.php

Future plans
Strix Cloud will continue to be extended with various functions that enhance the possibilities of online gaming. For official service start, we plan to add many features, including support for UnrealEngine and other game engines, network culling function required for MMO development, global chat function and other.
We will continue to contribute to the development of online content by constantly pursuing the best standards in the evolving network/server technology, increasing the performance of our solutions and maintaining the trust of our customers.

Contact information

Media inquiries:
Soft Gear Co., Ltd.
Chisato Hayashi
sg-info@soft-gear.co.jp
PR division
http://www.soft-gear.co.jp/en/

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Game of Thrones Winter is Coming™ Launches Worldwide25.3.2019 23:00:00 CETPressemelding

Yoozoo Games, a leading game developer and publisher, today announced the global launch of Game of Thrones Winter is Coming™ , a real-time strategy PC browser game officially licensed by Warner Bros. Interactive Entertainment under license from HBO®. The game is now available in English, with additional languages to follow. HBO, Warner Bros. Interactive Entertainment and Yoozoo Games have collaborated to recreate Westeros on a massive scale, delivering an authentic and immersive multiplayer world laid out across the Seven Kingdoms – complete with major landmarks and castles from the epic TV series. The story begins immediately following the death of Eddard Stark, when the player emerges as a new Westeros lord or lady in his stead. Strategising starts in earnest in Game of Thrones Winter is Coming as players aim to build an impenetrable base, train a victorious army and recruit faithful followers from a pool of iconic characters. As players progress, they must continue to acquire the mi

Earth Networks Announces Completion of Severe Weather Early Warning System for PAGASA25.3.2019 23:00:00 CETPressemelding

Earth Networks announced today the completion of the Philippines’ first nationwide severe weather monitoring and alerting network with associated software services for the Philippine Atmospheric, Geophysical, and Astronomical Services Administration (PAGASA), the National Meteorological and Hydrological Services (NMHS) agency of the Republic of the Philippines. The announcement was made at the 6th annual InterMET Asia conference in Singapore. Initiated in 2017, and formally commissioned this week, the technology partnership between PAGASA and Earth Networks is the first of its kind in the Philippines and surrounding regions, powered by a network of total lightning sensors and real-time automatic weather stations for mesoscale monitoring. Installed and operated together with Philippines partner West Point Engineering, the 10-year program includes: Real-time lightning detection powered by the Earth Networks Total Lightning Network On-the-ground weather monitoring via the Earth Networks W

bluebird bio Statement on European Regulatory Status of LentiGlobin™25.3.2019 22:40:00 CETPressemelding

A third party press release was issued today stating that the EMA (European Medicines Agency) issued an approval for the conditional Marketing Authorization Application (MAA) for LentiGlobin™, bluebird bio’s investigational gene therapy for the treatment of transfusion dependent β-thalassemia (TDT). LentiGlobin for TDT is scheduled to be reviewed as part of the CHMP (Committee on Human Medicinal Products) meeting from March 25 – 28, however no opinion has been issued by the CHMP. If the CHMP’s opinion is issued it would then be reviewed by the European Commission (EC), which has the authority to grant approval for the use of LentiGlobin in the EU. About bluebird bio, Inc. bluebird bio is pioneering gene therapy with purpose. From our Cambridge, Mass., headquarters, we’re developing gene therapies for severe genetic diseases and cancer, with the goal that people facing potentially fatal conditions with limited treatment options can live their lives fully. Beyond our labs, we’re working

Celgene Submits Application to FDA for Ozanimod for the Treatment of Relapsing Forms of Multiple Sclerosis25.3.2019 20:30:00 CETPressemelding

Celgene Corporation (NASDAQ:CELG) today announced that the Company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for ozanimod for the treatment of adults with relapsing forms of multiple sclerosis (RMS). Ozanimod is an oral, sphingosine 1-phosphate (S1P) receptor modulator, which binds with high affinity selectively to S1P subtypes 1 (S1P1) and 5 (S1P5). The pivotal efficacy and safety data provided in the application result from the SUNBEAM™ and RADIANCE™ Part B phase 3, multicenter, randomized, double-blind, double-dummy, active-controlled trials. “New oral treatment options with differentiated profiles like ozanimod are needed to help address an unmet need for people with relapsing forms of MS,” said Jay Backstrom, M.D., Chief Medical Officer for Celgene. “With concurrent applications in the U.S. and EU, we look forward to advancing this promising medicine through the regulatory review process to provide a new option for the treatment of RMS in

AVLT and UKTS Announce the European Medicines Agency’s Approval of the Conditional Marketing Authorization Application for Zynteglo™ (Previously Known as Lentiglobin™) Gene Therapy for the Treatment of Transfusion Dependent Beta Thalassaemia25.3.2019 19:50:00 CETPressemelding

Associazione Veneta Lotta alla Talassemia (AVLT) and the UK Thalassaemia Society (UKTS) announced today that the European Medicines Agency (EMA) has approved bluebird bio’s application for Conditional Marketing Authorization (cMAA) of their product Zynteglo™, a gene therapy for the treatment of adolescents and adults with transfusion-dependent β-thalassaemia (TDT) who do not have a β0/β0 genotype. As a result of this marketing authorisation, Zynteglo™ is now approved for use in all European countries covered by the European Medicines Agency. Zynteglo™ has been given ‘conditional authorisation’. This means that there is more evidence to be submitted, which the company is required to provide under specific obligations. Every year, the EMA will review any new information that becomes available. “People living with transfusion-dependent β-thalassaemia have a reduced life expectancy, requiring life-long frequent blood transfusions that are life-saving but may lead to complications, includin

Historic Partnership between the Weizmann Institute of Science and Institut Curie25.3.2019 16:54:00 CETPressemelding

On March 22, the Weizmann Institute of Science in Rehovot, Israel, and Institut Curie in Paris, France, two major world-class research institutes, signed an historic partnership that will allow their teams to work closely together to improve knowledge in the field of life sciences, particularly in the areas of physics and chemistry, and most specifically - in the field of cancer research. This is a milestone in the history of these two institutes that have been working together for 15 years, particularly in the field of biophysics. Collaborative research programs This partnership will extend to many disciplines, including physics, chemistry, cellular biology, epigenetics, genetics, immunology and single cell approaches, imagery and data collection. The complementarity of the research between the various groups at Institut Curie and at the Weizmann Institute has been recognized in particular at the occasion of joint scientific workshops held regularly alternatively in Paris and Rehovot.